Merck's ADC Drug Gets FDA Breakthrough Therapy Tag in NSCLC [Yahoo! Finance]
HSBC upgrades Merck stock to Buy on 2025 opportunities [Yahoo! Finance]
Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at HSBC Holdings plc from a "hold" rating to a "buy" rating. They now have a $130.00 price target on the stock.
Beam Therapeutics Expands its Board of Directors with Appointment of Chirfi Guindo, Global Biopharma Strategy and Commercial Leader [Yahoo! Finance]
TME Pharma Announces Corporate Strategy Update and Upcoming €2.6 Million Guaranteed Financing With Intention to Launch Public Offer Open Only to Shareholders to Enable Completion of Transactions Around NOX-A12 and NOX-E36 by June 2025 [Yahoo! Finance]